Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[shankapotamus]

If by "well done" you mean "overcooked", maybe. It's so full of hyperbole that it's hard to read it objectively.

At least one commenter hit the nail on the head IMO:

silence_twain Comments (108)

I am glad to see this article ends with another unsubstantiated claim about Anatabloc helping an individual. The only testimonial I have not yet seen is someone saying that by taking Anatabloc, an arm or leg they had lost has grown back. When someone brings up the Fred Couples endorsement, I always feel obligated to mention the Power Balance Bracelet. This was a bracelet endorsed by Shaq, Kobe, and Drew Brees among others. Even President Clinton wore one. The company was recently forced to shut down after losing a lawsuit that cost them $57 million because they stretched the truth about the bracelet. Athletes are not doctors (except Eric Heiden) and they can be fooled into thinking something is working when it is not.

With regards to the study, I did not need this study to tell me that nicotine possesses anti-inflammatory properties or that smoking has a few apparent positive actions. CIGX is simply testing for stuff that they already know to be true.

http://bit.ly/Ponycy

http://1.usa.gov/Q5GqL2


With regards to Alzheimer’s not mentioned in this piece, but often mentioned by those pumping Anatabloc, Envivo Pharmaceuticals seems to be way ahead of where Star is. Below is a Bloomberg article regarding EnVivo’s pill:

“EnVivo Pharmaceuticals Inc.’s pill designed to stimulate the same brain receptors as nicotine helped improve memory in Alzheimer’s patients after 23 weeks, an early trial showed. Patients given the drug at the highest dose improved on two measures of memory, according to data presented today at the Alzheimer’s Association International Conference in Vancouver. The subjects, who had mild to moderate disease, improved whether or not they were taking another Alzheimer’s medication. EnVivo’s drug targets the nicotinic A7 receptors, which are located in parts of the brain that help control learning. Like nicotine, the medicine activates the processes that boost learning and memory, without nicotine’s side-effects. Previous studies have suggested nicotine can enhance cognitive functions. “This is promising and has potential,” said Laurie Ryan, the program director for Alzheimer’s disease clinical trials at the National Institute on Aging in Bethesda, Maryland. The effect needs to be replicated in larger, later-stage trials, she said. “We’ve been talking a lot about pre-symptomatic trials, but we still need treatments for people with the full disease.” Alzheimer’s may affect 16 million Americans by 2050, an increase from 5.4 million now, according to U.S. health officials. While efforts are under way to delay or prevent the disease, people already diagnosed will need therapies to help them with the activities of daily living, Ryan said. EnVivo, based in Watertown, Massachusetts, tested more than 400 people, in four groups: with a placebo, a 0.3-milligram pill, a 1-milligram dose and a 2-milligram quantity. The 2-milligram dose had significant benefits over the placebo on two measures of thinking ability. The trial was the second of three phases typically required for U.S. regulatory approval. The closely held company is examining its options for Phase 3 trials, said Kees Been, chief executive officer of EnVivo. Though EnVivo wants to commercialize the drugs, the company will need a partner, Been said in an interview. “The world is very large, and too big for us on our own,” Been said.”

I know everyone who is long CIGX wants to believe that this shady company that has never turned a profit all of a sudden has a cure all product. They do not. What they have is an over the counter dietary supplement. No more no less. In fact, the FDA has not even said that the product is a proven to help with inflammation. Those are claims that are simply being made by Star. My guess is it is simply more of the same snake-oil that Johnnie Williams and company has been peddling since the company began.

As for something working in mice, thousands of studies have worked in mice that ultimately amounted to nothing.

Keep up the good pump. Can’t wait until nothing comes from the mediation with Reynolds. Just for fun, I will throw in an updated valuation. Star has 1.2 million in sales last quarter and currently has a market cap of 550 million. Even if we assume that Anatabloc does 10 million in sales this year (I don’t think it will come close, but let’s assume), that implies a p/sales multiple of 55 if the stock does not move a penny.

To all the longs: Feel free to attack away!